Direct Health-care Cost of Noncommunicable Diseases in Malaysia

A new report from the Ministry of Health (MOH) Malaysia and the World Health Organization (WHO), Direct Health-care Cost of Noncommunicable Diseases in Malaysia, reveals that hospitalizations, medical tests, medications, and primary care consultations of noncommunicable diseases (NCDs), particularly cardiovascular diseases, diabetes and cancer, annually cost the Malaysian economy upwards of RM 9.65 billion.

The report released today utilized data from the year 2017. The secured data were largely restricted to the public sector, and extrapolations to the private sector were based on assumptions. While the cost estimates are based on the best available data, they no doubt underestimate the real cost of the direct health-care costs associated with NCDs in Malaysia.